Abstract:P2X receptors are extracellular ATP-gated ion channels that form homo-or heterotrimers and consist of seven subtypes. They are expressed in various tissues, including neuronal and nonneuronal cells, and play critical roles in physiological processes such as neurotransmission, inflammation, pain, and cancer. As a result, P2X receptors have attracted considerable interest as drug targets, and various competitive inhibitors have been developed. However, although several P2X receptor structures from different subtypes have been reported, the limited structural information of P2X receptors in complex with competitive antagonists hampers the understanding of orthosteric inhibition, hindering the further design and optimization of those antagonists for drug discovery. Here, we determined the cryo-EM structures of the mammalian P2X7 receptor in complex with two classical competitive antagonists of pyridoxal-5’-phosphate derivatives, PPNDS and PPADS, at 3.3 and 3.6 Å resolution, respectively, and performed structure-based mutational analysis by patch-clamp recording as well as MD simulations. Our structures revealed the orthosteric site for PPADS/PPNDS, and structural comparison with the previously reported apo-and ATP-bound structures showed how PPADS/PPNDS binding inhibits the conformational changes associated with channel activation. In addition, structure-based mutational analysis identified key residues involved in the PPNDS sensitivity of P2X1 and P2X3, which are known to have higher affinity for PPADS/PPNDS than other P2X subtypes. Overall, our work provides structural insights into the orthosteric inhibition and subtype specificity of P2X receptors by the classical P2X antagonists, pyridoxal-5’-phosphate derivatives, thereby facilitating the rational design of novel competitive antagonists for P2X receptors.

P2X7 receptors exhibit at least three modes of allosteric antagonism

P2X 7 receptors exhibit at least three modes of allosteric antagonism

Ionotropic purinergic receptor 7 (P2X7) channel structure and pharmacology provides insight regarding non-nucleotide agonism

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP analog antagonists

Structural insights into the orthosteric inhibition of P2X receptors by non-ATP-analog antagonists

High-affinity agonism at the P2X7 receptor is mediated by three residues outside the orthosteric pocket

Structural Insights into the Allosteric Inhibition of P2X4 Receptors

Cryo-EM structures of the human P2X1 receptor reveal subtype-specific architecture and antagonism by supramolecular ligand-binding

Identification of Novel P2X7R Antagonists by Using Structure‐based Virtual Screening and Cell‐based Assays

Human P2X4 receptor gating is modulated by a stable cytoplasmic cap and a unique allosteric pocket

Molecular determinants for agonist recognition and discrimination in P2X2 receptors

Structural Insights into the Competitive Inhibition of the ATP-gated P2X Receptor Channel

A shared mechanism for TNP-ATP recognition by members of the P2X receptor family

Druggable negative allosteric site of P2X3 receptors

Full-Length P2X7 Structures Reveal How Palmitoylation Prevents Channel Desensitization

A Second Drug Binding Site in P2X3

Subtype-Specific Ligand Binding and Activation Gating in Homomeric and Heteromeric P2X Receptors

Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists

Pharmacological differences between human and mouse P2X4 receptor explored using old and new tools

Molecular Mechanisms of Human P2X3 Receptor Channel Activation and Modulation by Divalent Cation Bound ATP

Screening herbal and natural product libraries to aid discovery of novel allosteric modulators of human P2X7